Adenocarcinoma Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Oral TGF-beta Receptor I Inhibitor Vactosertib in SOC Chemoradiotherapy for Adenocarcinoma
Conditions: Adenocarcinoma Esophagus; Locally Advanced Adenocarcinoma; Siewert Type I Adenocarcinoma of Esophagogastric Junction; Siewert Type II Adenocarcinoma of Esophagogastric Junction Interventions: Drug: Vactosertib; Drug: Standard of Care Chemotherapy; Radiation: Concurrent Radiation Sponsor: Jennifer Eva Selfridge Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials

PSMA PET Response Guided SabR in High Risk Pca
Condition: Prostate Adenocarcinoma Intervention: Drug: 68-Ga PSMA11 Sponsors: University of Texas Southwestern Medical Center; Once Upon a Time Foundation; Telix International Pty Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials

Clinical, Genetic and Environmental Determinants of Prostate Cancer Progression.
Conditions: Prostatic Neoplasm; Adenocarcinoma; Neoplasm Recurrence; Neoplasm Metastasis Intervention: Other: Standard care Sponsors: Centre Hospitalier Universitaire de Pointe-a-Pitre; Institut National de la Santé Et de la Recherche Médicale, France Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials

Efficacy of First-Line Gemcitabine Chemotherapy in GemCore+ Metastatic Pancreatic Adenocarcinoma Patients
Condition: Cancer Of Pancreas Intervention: Other: Analyze of GemCore status Sponsor: Institut Paoli-Calmettes Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Conditions: Diffuse Astrocytoma, IDH-Mutant; Glioblastoma, IDH-wildtype; Brain Metastases, Adult; Cervical Cancer; Colorectal Cancer; Esophageal Cancer; Esophageal Squamous Cell Carcinoma; Gastric Cancer; Gastroesophageal Junction Adenocarcinoma; Head and Neck Squ amous Cell Carcinoma; Melanoma; Merkel Cell Carcinoma; Microsatellite Instability-High Solid Malignant Tumor; Mismatch Repair Deficient Solid Malignant Tumor; Microsatellite Instability-High Colorectal Cancer; Mismatch Repair Deficient Colorectal Cancer; Non-smal l Cell Lung Ca...
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials

Early Access Program for Zolbetuximab
Conditions: Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma Cancer; Locally Advanced Unresectable Gastric Adenocarcinoma Cancer; Metastatic Gastric Adenocarcinoma Cancer; Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma Intervention: Drug: zolbetuximab Sponsor: Astellas Pharma Global Development, Inc. Available (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials

Combination Therapy in Patients With Localized Pancreatic Ductal Adenocarcinoma
Condition: Pancreatic Ductal Adenocarcinoma Interventions: Radiation: Stereotactic body radiotherapy (SBRT); Drug: Zimberelimab; Drug: Quemliclustat; Drug: Etrumadenant; Drug: Modified FOLFIRINOX Sponsors: Gulam Manji; Arcus Biosciences, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials

Paclitaxel and Ramucirumab +/- Zanidatamab in HER2 Postive Advanced Gastroesophageal Adenocarcinoma
Condition: Gastroesophageal Adenocarcinoma Interventions: Drug: Paclitaxel; Drug: Ramucirumab; Drug: Zanidatamab Sponsors: Canadian Cancer Trials Group; Jazz Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials